Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hidradenitis Suppurativa
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
PBMI 2026|
PBMI Innovators|
AIDS 2026|
State of the Industry survey: Share your 2027 outlook
Advertisement

Diane Doherty

Advertisement

Articles by Diane Doherty

Four risks healthcare executives should monitor in 2018

ByDiane Doherty
December 30th 2017

With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.

Advertisement

Latest Updated Articles

  • Four risks healthcare executives should monitor in 2018
    Four risks healthcare executives should monitor in 2018

    December 30th 2017



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns

2

Heart data in sleep study predicts atrial fibrillation, heart failure years in advance

3

For bronchiectasis, a new era of guideline-guided care | CHEST 2026

4

Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations

5

On delayed diagnosis and possible causes of hidradenitis suppurativa | A Q&A with Luis Garza, M.D., Ph.D.

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us